Schering-Plough Animal Health's goal is to help keep animals healthy and help make your practice more efficient and profitable. It is a commitment to excellence that dates back to our beginnings.

Since 1921 Schering-Plough Animal Health has been dedicated to developing, perfecting and introducing the most innovative and effective products for all aspects of the poultry producing industry. The development of vaccines for diseases such as bordetella, E. coli, fowl cholera and reovirus, as well as the discovery of new and more effective antibiotics to control chick mortality have been at the center of our efforts for many years.

Today, these innovative biologicals and pharmaceuticals are backed by greater corporate strength, research and service � all of which translates directly into greater service and success for the poultry producers and veterinarians.

With our facilities worldwide, we constantly monitor the emerging diseases and develop new technologies which help to maintain an animal's health. In fact, Schering-Plough spends millions of dollars on research and development in a single year.

This financial commitment supports our philosophy of growth through research. This has contributed to Schering-Plough being recognized globally as an innovator and manufacturer of world class vaccines and pharmaceuticals.

Of course, our dedication to research is second only to our commitment to you. That is why we will continue to serve as a global, research-based company engaged in the discovery, development and manufacturing of animal health solutions. Solutions that aid the success of your practice.